US Stock MarketDetailed Quotes

Structure Therapeutics (GPCR)

Watchlist
  • 88.715
  • +3.695+4.35%
Trading Jan 16 15:29 ET
6.13BMarket Cap-24.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics (GPCR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
60.98%73.79M
111.46%70.45M
75.89%56.31M
53.96%158.23M
51.84%47.06M
75.31%45.84M
28.20%33.32M
62.93%32.02M
95.53%102.78M
139.23%30.99M
Selling and administrative expenses
11.78%14.8M
39.72%15.74M
18.60%13.44M
51.24%49.41M
23.94%13.57M
53.40%13.24M
71.32%11.27M
74.03%11.34M
99.61%32.67M
138.29%10.95M
-General and administrative expense
11.78%14.8M
39.72%15.74M
18.60%13.44M
51.24%49.41M
23.94%13.57M
53.40%13.24M
71.32%11.27M
74.03%11.34M
99.61%32.67M
138.29%10.95M
Research and development costs
80.96%58.99M
148.12%54.71M
107.30%42.87M
55.22%108.81M
67.08%33.49M
86.11%32.6M
13.60%22.05M
57.43%20.68M
93.69%70.1M
139.74%20.04M
Operating profit
-60.98%-73.79M
-111.46%-70.45M
-75.89%-56.31M
-53.96%-158.23M
-51.84%-47.06M
-75.31%-45.84M
-28.20%-33.32M
-62.93%-32.02M
-95.53%-102.78M
-139.23%-30.99M
Net non-operating interest income expense
-31.53%8.18M
21.73%8.93M
59.39%9.58M
168.93%36.01M
73.46%10.72M
344.61%11.95M
159.65%7.34M
253.62%6.01M
965.31%13.39M
585.79%6.18M
Total other finance cost
31.53%-8.18M
-21.73%-8.93M
-59.39%-9.58M
-168.93%-36.01M
-73.46%-10.72M
-344.61%-11.95M
-159.65%-7.34M
-253.62%-6.01M
-965.31%-13.39M
-585.79%-6.18M
Other net income (expense)
Income before tax
-93.61%-65.6M
-136.80%-61.52M
-79.70%-46.74M
-36.73%-122.22M
-46.46%-36.34M
-44.46%-33.89M
-12.17%-25.98M
-44.89%-26.01M
-74.22%-89.38M
-105.85%-24.82M
Income tax
17.39%108K
162.26%139K
237.93%98K
31.36%310K
143.59%136K
-77.28%92K
-55.08%53K
16.00%29K
1,288.24%236K
-73.33%-312K
Net income
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-74.63%-89.62M
-106.34%-24.5M
Net income continuous Operations
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-74.63%-89.62M
-106.34%-24.5M
Minority interest income
Net income attributable to the parent company
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-74.63%-89.62M
-106.34%-24.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-93.40%-65.71M
-136.85%-61.66M
-79.88%-46.83M
-36.72%-122.53M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-69.62%-89.62M
-106.34%-24.5M
Basic earnings per share
-85.00%-1.11
-100.00%-1.08
-42.11%-0.81
3.70%-2.34
-32.66%-0.6368
4.76%-0.6
10.00%-0.54
24.00%-0.57
-75.89%-2.43
-54.58%-0.48
Diluted earnings per share
-85.00%-1.11
-100.00%-1.08
-42.11%-0.81
3.70%-2.34
-32.66%-0.6368
4.76%-0.6
10.00%-0.54
24.00%-0.57
-75.89%-2.43
-54.58%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 60.98%73.79M111.46%70.45M75.89%56.31M53.96%158.23M51.84%47.06M75.31%45.84M28.20%33.32M62.93%32.02M95.53%102.78M139.23%30.99M
Selling and administrative expenses 11.78%14.8M39.72%15.74M18.60%13.44M51.24%49.41M23.94%13.57M53.40%13.24M71.32%11.27M74.03%11.34M99.61%32.67M138.29%10.95M
-General and administrative expense 11.78%14.8M39.72%15.74M18.60%13.44M51.24%49.41M23.94%13.57M53.40%13.24M71.32%11.27M74.03%11.34M99.61%32.67M138.29%10.95M
Research and development costs 80.96%58.99M148.12%54.71M107.30%42.87M55.22%108.81M67.08%33.49M86.11%32.6M13.60%22.05M57.43%20.68M93.69%70.1M139.74%20.04M
Operating profit -60.98%-73.79M-111.46%-70.45M-75.89%-56.31M-53.96%-158.23M-51.84%-47.06M-75.31%-45.84M-28.20%-33.32M-62.93%-32.02M-95.53%-102.78M-139.23%-30.99M
Net non-operating interest income expense -31.53%8.18M21.73%8.93M59.39%9.58M168.93%36.01M73.46%10.72M344.61%11.95M159.65%7.34M253.62%6.01M965.31%13.39M585.79%6.18M
Total other finance cost 31.53%-8.18M-21.73%-8.93M-59.39%-9.58M-168.93%-36.01M-73.46%-10.72M-344.61%-11.95M-159.65%-7.34M-253.62%-6.01M-965.31%-13.39M-585.79%-6.18M
Other net income (expense)
Income before tax -93.61%-65.6M-136.80%-61.52M-79.70%-46.74M-36.73%-122.22M-46.46%-36.34M-44.46%-33.89M-12.17%-25.98M-44.89%-26.01M-74.22%-89.38M-105.85%-24.82M
Income tax 17.39%108K162.26%139K237.93%98K31.36%310K143.59%136K-77.28%92K-55.08%53K16.00%29K1,288.24%236K-73.33%-312K
Net income -93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M-44.85%-26.04M-74.63%-89.62M-106.34%-24.5M
Net income continuous Operations -93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M-44.85%-26.04M-74.63%-89.62M-106.34%-24.5M
Minority interest income
Net income attributable to the parent company -93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M-44.85%-26.04M-74.63%-89.62M-106.34%-24.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -93.40%-65.71M-136.85%-61.66M-79.88%-46.83M-36.72%-122.53M-48.88%-36.48M-42.39%-33.98M-11.83%-26.03M-44.85%-26.04M-69.62%-89.62M-106.34%-24.5M
Basic earnings per share -85.00%-1.11-100.00%-1.08-42.11%-0.813.70%-2.34-32.66%-0.63684.76%-0.610.00%-0.5424.00%-0.57-75.89%-2.43-54.58%-0.48
Diluted earnings per share -85.00%-1.11-100.00%-1.08-42.11%-0.813.70%-2.34-32.66%-0.63684.76%-0.610.00%-0.5424.00%-0.57-75.89%-2.43-54.58%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.35%
Sample Name
Sample Code
 +2.78%
Sample Name
Sample Code
 +2.44%
4
American Express
AXP
+2.38%
5
Block
XYZ
+1.16%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.68%
Sample Name
Sample Code
 +10.32%
Sample Name
Sample Code
 +9.58%
4
Kingsoft Cloud
KC
+7.53%
5
United Microelectronics
UMC
+6.20%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -